Researchers find new mechanism to turn on cancer-killing T cells

A new mechanism involved in the anti-cancer immune response has been identified and may have implications for targeting antigens.

Hans Schreiber receives inaugural Jonas Memorial Award for contributions to cellular immunotherapy
Novel biomarker predicts how non-small cell lung cancer will progress after immunotherapy